HIMS Earnings Date: Nov 9, 2026 (Estimated) — Hims & Hers Health, Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is HIMS's next earnings date?
Hims & Hers Health, Inc. (HIMS) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.06 on revenue of $892.9M.
How did HIMS do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Hims & Hers Health, Inc. posted EPS of -$0.37 versus the -$0.05 estimate, a miss of 640.0%. Revenue was $753.2M against a $698.9M estimate. The stock's 1-day post-earnings move was -4.0%.
How much does HIMS stock move after earnings?
HIMS beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 11.0% (up or down) in the day after earnings.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.05 | -0.37 | -640.00% | $753.2M | ❌ Miss | -3.97% | -9.95% | -12.18% |
| 2026-05-11 | Q1 2026 | 0.04 | -0.40 | -1100.00% | $608.1M | ❌ Miss | -14.10% | -23.51% | -4.67% |
| 2026-02-23 | Q4 2025 | 0.03 | 0.08 | +166.67% | $617.8M | ✅ Beat | -0.32% | +6.25% | +37.59% |
| 2025-11-03 | Q3 2025 | 0.10 | 0.09 | -10.00% | $599.0M | ❌ Miss | -3.60% | -7.52% | -16.49% |
| 2025-08-04 | Q2 2025 | 0.21 | 0.17 | -19.05% | $544.8M | ❌ Miss | -12.36% | -21.11% | -29.82% |
| 2025-02-24 | Q4 2024 | 0.10 | 0.11 | +10.00% | $481.1M | ✅ Beat | -22.32% | -20.72% | -27.81% |
| 2024-11-04 | Q3 2024 | 0.04 | 0.32 | +700.00% | $401.6M | ✅ Beat | -0.58% | +34.30% | +63.39% |
| 2024-02-26 | Q4 2023 | -0.02 | 0.01 | +150.00% | $246.6M | ✅ Beat | +31.02% | +43.41% | +54.34% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $753.2M total
| Segment | Share | Revenue | YoY | Q2 FY26 |
|---|---|---|---|---|
| UNITED STATES | 82.6% | $621.8M | — | $621.8M |
| Non-US | 17.4% | $131.4M | — | $131.4M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.